These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 34061205)

  • 41. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
    Anderson RM; Vegvari C; Truscott J; Collyer BS
    Lancet; 2020 Nov; 396(10263):1614-1616. PubMed ID: 33159850
    [No Abstract]   [Full Text] [Related]  

  • 42. COVID 19 vaccination lessons from Japanese anti-HPV vaccination lobby.
    Fujiwara K; Quinn MA
    Int J Gynecol Cancer; 2020 Aug; 30(8):1255. PubMed ID: 32624498
    [No Abstract]   [Full Text] [Related]  

  • 43. Attitudes of Healthcare Personnel towards Vaccinations before and during the COVID-19 Pandemic.
    Ledda C; Costantino C; Cuccia M; Maltezou HC; Rapisarda V
    Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33800187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nonpharmaceutical interventions for tackling the COVID-19 epidemic in Brazil.
    Garcia LP; Duarte E
    Epidemiol Serv Saude; 2020 Apr; 29(2):e2020222. PubMed ID: 32294756
    [No Abstract]   [Full Text] [Related]  

  • 45. Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
    Covián C; Retamal-Díaz A; Bueno SM; Kalergis AM
    Front Immunol; 2020; 11():970. PubMed ID: 32574258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implementing digital passports for SARS-CoV-2 immunization in Canada.
    Wilson K; Flood CM
    CMAJ; 2021 Apr; 193(14):E486-E488. PubMed ID: 33658246
    [No Abstract]   [Full Text] [Related]  

  • 47. Projected effects of nonpharmaceutical public health interventions to prevent resurgence of SARS-CoV-2 transmission in Canada.
    Ng V; Fazil A; Waddell LA; Bancej C; Turgeon P; Otten A; Atchessi N; Ogden NH
    CMAJ; 2020 Sep; 192(37):E1053-E1064. PubMed ID: 32778573
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparing for COVID-19 Vaccination: A Call to Action for Clinicians on Immunization Information Systems.
    Trotter AB; Abbott EK; Coyle R; Shen AK
    Ann Intern Med; 2021 May; 174(5):695-697. PubMed ID: 33524294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased COVID-19 Vaccination Hesitancy and Health Awareness amid COVID-19 Vaccinations Programs in Israel.
    Shacham M; Greenblatt-Kimron L; Hamama-Raz Y; Martin LR; Peleg O; Ben-Ezra M; Mijiritsky E
    Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33917327
    [TBL] [Abstract][Full Text] [Related]  

  • 50. COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
    Laine C; Cotton D; Moyer DV
    Ann Intern Med; 2021 Mar; 174(3):413-414. PubMed ID: 33492990
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The COVID-19 exit strategy-why we need to aim low.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2021 Mar; 21(3):297. PubMed ID: 33581748
    [No Abstract]   [Full Text] [Related]  

  • 52. COVID-19: Predictions for SARS-CoV-2 vaccination on the course of the pandemic and critical occupancy of intensive-care facilities in Germany.
    Braun P; Braun J; Woodcock BG
    Int J Clin Pharmacol Ther; 2021 Apr; 59(4):269-279. PubMed ID: 33605876
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Coronavirus Pandemic 1 Year On-What Went Wrong?
    Gostin LO
    JAMA; 2021 Mar; 325(12):1132-1133. PubMed ID: 33755061
    [No Abstract]   [Full Text] [Related]  

  • 54. Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey.
    Goldman RD; Yan TD; Seiler M; Parra Cotanda C; Brown JC; Klein EJ; Hoeffe J; Gelernter R; Hall JE; Davis AL; Griffiths MA; Mater A; Manzano S; Gualco G; Shimizu N; Hurt TL; Ahmed S; Hansen M; Sheridan D; Ali S; Thompson GC; Gaucher N; Staubli G;
    Vaccine; 2020 Nov; 38(48):7668-7673. PubMed ID: 33071002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 in Turkey: a nation on edge.
    Genç K
    Lancet; 2021 May; 397(10287):1794-1796. PubMed ID: 33992132
    [No Abstract]   [Full Text] [Related]  

  • 56. BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.
    Queiroz NSF; Teixeira FV; Freire CCF; Motta MP; Vasconcellos MAM; Chebli LA; Saad-Hossne R;
    Arq Gastroenterol; 2021; 58(1):1-4. PubMed ID: 33909805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. When is it reasonable to extrapolate during a pandemic?: The case of broad UK labeling for AstraZeneca COVID-19 vaccine.
    Dal-Ré R; Banzi R
    Eur J Intern Med; 2021 May; 87():1-2. PubMed ID: 33810939
    [No Abstract]   [Full Text] [Related]  

  • 58. From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development.
    Ma C; Su S; Wang J; Wei L; Du L; Jiang S
    Microbes Infect; 2020; 22(6-7):245-253. PubMed ID: 32437926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Planning for a COVID-19 Vaccination Program.
    Schaffer DeRoo S; Pudalov NJ; Fu LY
    JAMA; 2020 Jun; 323(24):2458-2459. PubMed ID: 32421155
    [No Abstract]   [Full Text] [Related]  

  • 60. Nonpharmaceutical Interventions Used to Control COVID-19 Reduced Seasonal Influenza Transmission in China.
    Lei H; Xu M; Wang X; Xie Y; Du X; Chen T; Yang L; Wang D; Shu Y
    J Infect Dis; 2020 Nov; 222(11):1780-1783. PubMed ID: 32898256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.